MAZE
Price
$31.26
Change
+$2.83 (+9.95%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
1.73B
45 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$2.04
Change
+$0.15 (+7.94%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
416.56M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MAZE vs PROK

MAZE vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MAZE vs. PROK commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAZE is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (MAZE: $28.43 vs. PROK: $1.83)
Brand notoriety: MAZE and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MAZE: 401% vs. PROK: 521%
Market capitalization -- MAZE: $1.73B vs. PROK: $416.56M
MAZE [@Biotechnology] is valued at $1.73B. PROK’s [@Biotechnology] market capitalization is $416.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAZE’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • MAZE’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, MAZE is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAZE’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • MAZE’s TA Score: 5 bullish, 5 bearish.
  • PROK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than MAZE.

Price Growth

MAZE (@Biotechnology) experienced а +5.22% price change this week, while PROK (@Biotechnology) price change was +7.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

MAZE is expected to report earnings on Aug 18, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAZE($1.73B) has a higher market cap than PROK($417M). PROK YTD gains are higher at: -18.304 vs. MAZE (-31.378). MAZE has higher annual earnings (EBITDA): -131.29M vs. PROK (-149.81M). MAZE has more cash in the bank: 352M vs. PROK (225M). PROK has less debt than MAZE: PROK (3.78M) vs MAZE (61.2M). MAZE has higher revenues than PROK: MAZE (20M) vs PROK (889K).
MAZEPROKMAZE / PROK
Capitalization1.73B417M415%
EBITDA-131.29M-149.81M88%
Gain YTD-31.378-18.304171%
P/E Ratio191.34N/A-
Revenue20M889K2,250%
Total Cash352M225M156%
Total Debt61.2M3.78M1,618%
TECHNICAL ANALYSIS
Technical Analysis
MAZEPROK
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
90%
Bullish Trend 17 days ago
73%
Declines
ODDS (%)
Bearish Trend 27 days ago
82%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
MAZE
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFLX25.990.51
+2.00%
Morgan Stanley Inst Global Franchise L
JDVVX29.260.08
+0.27%
JHancock Disciplined Value R5
MSEFX11.960.03
+0.25%
iMGP Global Select Instl
AFOIX23.02-0.27
-1.16%
Alger Mid Cap Focus I
FESAX14.89-0.35
-2.30%
First Eagle Small Cap Opportunity A

MAZE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
N/A
AVXL - MAZE
40%
Loosely correlated
N/A
PROK - MAZE
37%
Loosely correlated
N/A
IMNM - MAZE
33%
Loosely correlated
N/A
ADMA - MAZE
30%
Poorly correlated
N/A
BEAM - MAZE
30%
Poorly correlated
N/A
More